Proteonomix Inc.

Proteonomix Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$276.89 K
Shares Outstanding
7.91 M
Public Float
6.54 M

Profile

Address
140 East Ridgewood Avenue
Paramus New Jersey 07652
United States
Employees -
Website mailto:info@proteonomix.com
Updated 07/08/2019
Proteonomix, Inc. is a biotechnology company which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. It develops pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. Proteonomix was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Hawthorne, NJ.

Financials

View All
Created with Highcharts 5.0.14Proteonomix Inc.Net Income. Fiscal year is January-December. All values USD Thousands.4 9694 9693 8583 8583 4703 4701 3831 383200820092010201101k2k3k4k5k6k
Created with Highcharts 5.0.14Proteonomix Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1321321411418383262620082009201020110255075100125150

Michael Moshe Cohen
Chairman, President, CEO, COO, CAO & Controller
Steven Mark Byle
Director & Chief Technology Officer